Key facts
- This page summarizes John L. Workman's Form 4 filing for CONMED Corp (CNMD).
- 4 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 02 Jun 2022, 21:29.
John L. Workman - 01 Jun 2022 Form 4 Insider Report for CONMED Corp (CNMD)
- Reporting relationship
- Director
- Issuer ticker
- CNMD
- Reported as of
- 01 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Jun 2022, 21:29:25 UTC
- Prior SEC filing
- 26 Apr 2022
- Next SEC filing
- 14 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- Sarah M. Oliker for John L. Workman by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John L. Workman filed Form 4 for CONMED Corp (CNMD) on 02 Jun 2022.
Change
- Previous filing in this sequence was filed on 26 Apr 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CNMD
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +812
- Change %
- +4.3%
- Price
- $0.000000
- Shares after
- 19,775
- Date
- 01 Jun 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CNMD
transaction
Derivative
Rsus (restricted Stock Units)
Options Exercise
- Transaction value
- $0
- Shares
- -812
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 01 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 812
- Exercise price
- $0.000000
- Footnotes
- F1
CNMD
transaction
Derivative
Options To Purchase Common Stock
Award
- Transaction value
- $0
- Shares
- +3,453
- Change %
- Price
- $0.000000
- Shares after
- 3,453
- Date
- 01 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,453
- Exercise price
- $111.79
- Footnotes
- F2
CNMD
transaction
Derivative
Rsus (restricted Stock Units)
Award
- Transaction value
- $0
- Shares
- +335
- Change %
- Price
- $0.000000
- Shares after
- 335
- Date
- 01 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 335
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
Footnote F2
The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.